Frontiers in Cardiovascular Medicine

JANUARY 10, 2024

Introduction Heart transplantation (HT) is the only treatment option in children with heart failure secondary to cardiomyopathies and non-reparable congenital heart diseases. One patient developed a complete AV block during acute rejection at 76 months and received a temporary pacemaker.

Heart Transplant 59

Heart Transplant Transplant Arrhythmia Pacemaker 59

Journal of Cardiothoracic Surgery

SEPTEMBER 4, 2024

The preferred treatment is surgical resection, but antiarrhythmic medications or heart transplantation have also been used previously. Cardiac fibromas are extremely rare in adults. The cardiac imaging, partic.

Heart Transplant 40

Heart Transplant Transplant Tachycardia 40

The British Journal of Cardiology

DECEMBER 3, 2024

A 74-year-old man with a heterotopic heart transplant experienced alternating episodes of sustained native heart ventricular tachycardia and prolonged asystole. These were managed with cardioversion, drug therapy and pacemaker insertion.

Heart Transplant 40

Heart Transplant Transplant Pacemaker Physiology 40

Journal of Cardiovascular Electrophysiology

JANUARY 15, 2024

Abstract Introduction Atrial fibrillation and atrial flutter originating from the donor s heart is a commonly reported complication post heart transplant. Case A 47-year-old male presented with atrial tachycardia 6 months post heart transplant.

Atrial Fibrillation 40

Atrial Fibrillation Heart Transplant Atrial Flutter Transplant 40

Dr. Smith's ECG Blog

JUNE 2, 2023

She was awake, alert, well perfused, with normal mental status and overall unremarkable physical exam except for a regular tachycardia, possible rales at both bases, some mild RUQ abdominal tenderness. Thus, I believe it is a regular, monomorphic, wide complex tachycardia. Or it could simply still be classic VT. What is the Diagnosis?

Tachycardia 96

Tachycardia Cardiomyopathy Electrocardiogram Article 96

DAIC

APRIL 30, 2024

Heart attacks typically kill millions of cardiac muscle cells, leaving the heart in a weakened state. Since mammals cannot regenerate cardiac muscle cells on their own, heart transplants are currently the only clinically viable option for patients suffering (or likely to suffer) heart failure.

Transplant 105

Transplant Heart Transplant Myocardial Infarction Heart Attack 105

Journal of Cardiovascular Electrophysiology

DECEMBER 17, 2024

Given the efficacy of other class III agents, it has been used off-label for the treatment of premature ventricular complexes (PVCs) and ventricular tachycardias (VTs). The composite outcome of VT/VF recurrence, heart transplantation, or death occurred in 6/12 patients (50%) without dofetilide and 49/69 patients (71%) with dofetilide.

Tachycardia 40

Tachycardia Heart Disease Atrial Flutter Heart Transplant 40